Menu
Welcome To
ISPOR 2025 United Arab Emirates Chapter Conference
Join HEOR leaders, policymakers, and innovators at the first-ever ISPOR UAE Chapter conference!
50+
Speakers
Welcome To
ISPOR 2025 United Arab Emirates Chapter Conference
Join HEOR leaders, policymakers, and innovators at the first-ever ISPOR UAE Chapter conference!
Event Location
Rosewood Hotel Abu Dhabi
Event Time
23-24 May, 2025
Welcome Message
We are delighted to welcome you to join us at the ISPOR 2025 United Arab Emirates Chapter Conference, taking place at Rosewood Hotel, Abu Dhabi, on May 23-24, 2025.
Our must-attend event offers a dynamic program featuring esteemed keynote speakers, engaging discussions, and insightful scientific poster presentations.
We hope you find the conference both inspiring and valuable, fostering meaningful connections with peers and industry leaders while sparking innovative ideas.
We look forward to your participation!
Best regards,
Professor Nadia Al Mazrouei,
ISPOR UAE Chapter President Assoc. Professor in Sharjah University Abu Dhabi Emirate, United Arab Emirates
Objectives:
-
Advancing Patient-Centered Healthcare: Promote discussions on value-based care to deliver patient-centered outcomes and integrate the perspectives of patients and stakeholders in HEOR discussions to ensure equitable and efficient healthcare solutions.
-
Empowering Local Expertise for Global Impact: Showcase the contributions of UAE-based HEOR experts in shaping regional and international healthcare strategies and encourage capacity building and knowledge sharing to empower local professionals, fostering a thriving HEOR community.
-
Bridging Research and Practice in a Digital Era: Highlight advancements in digital health technologies, such as AI and data analytics, to bridge the gap between HEOR research and real-world applications and facilitate discussions on the integration of digital tools to enhance patient outcomes and optimize healthcare costs in the UAE and globally.
ISPOR 2025 United Arab Emirates Chapter Conference
Sessions Recordings
Exclusive Access for Members
Session I: “Transforming Healthcare – Patient-Centered Approaches and Personalized Care”
Integrating Patient Preferences in Health Technologies Decision-Making
Session I: “Transforming Healthcare – Patient-Centered Approaches and Personalized Care” Moderated by: Dr. Marleine Moukarzel, Pharmacy Director, Sheikh Shakhbout Medical City, UAE Dr. Lina Wahba, Head of Clinical Pharmacy Services-Tawam- Adjunct Assistant Professor-CMHS UAE university- SEHA pharmacy residency program-Tawam Site director-UAE By: Prof. Ibrahim Alabbadi Professor of Pharmacoeconomics and Pharmaceutical Marketing - The University of Jordan, Jordan
Economic Evaluations and Personalized Care in Healthcare Systems
Session I: “Transforming Healthcare – Patient-Centered Approaches and Personalized Care” Moderated by: Dr. Marleine Moukarzel, Pharmacy Director, Sheikh Shakhbout Medical City, UAE Dr. Lina Wahba, Head of Clinical Pharmacy Services-Tawam- Adjunct Assistant Professor-CMHS UAE
university- SEHA pharmacy residency program-Tawam Site director-UAE By: Prof. Daoud Al-Badriyeh, Professor of Pharmacoeconomics and Outcomes Research at Qatar University, Qatar
Session II: “Redefining Healthcare: Bridging Health Equity and Value-Based Care”
Opening presentation for the panel: “Innovating HEOR for Health Equity: Advancing Value-Based Care, Disease Burden Assessment, and Productivity Measures”
Session II: “Redefining Healthcare: Bridging Health Equity and Value-Based Care” Moderated by: Dr. Aisha ALDhanhani, ISPOR UAE Chapter Board Director, Senior Pharmaceutical Procurement Manager, Rafed, UAE By: Dr. Tomasz Kluszczynski, Professor at Warsaw University of Technology and Goethe Frankfurt University, Poland
Panel Discussion: Advancing Health Equity through Value-Based Healthcare - Economic Burden of Rare Diseases and Orphan Drugs in MENA
Session II: “Redefining Healthcare: Bridging Health Equity and Value-Based Care”
Advancing Health Equity through Value-Based Healthcare - Economic Burden of Rare Diseases and Orphan Drugs in MENA
Chairperson:
Dr. Tomasz Kluszczynski, Professor at Warsaw University of Technology and Goethe Frankfurt University, Poland
Panelists:
Dr. Aisha ALDhanhani, ISPOR UAE Chapter Board Director, Senior Pharmaceutical Procurement Manager, Rafed, UAE
Dr. Amal Yassine, Member of the ISPOR Morocco Chapter Board and General Secretary of the Moroccan Society for Health Products Economics (SMEPS), Morroco
Dr. Khadeija Al-Marshoudi, ISPOR UAE Chapter Board Director, Head of Planning and Development Section at Emirates Health Service, UAE
Dr. Khuloud Jamal Bin Rafeea, Director of Drug compliance and Quality Assurance – DoH, UAE
Dr. Ibtisam Alharbi, Health Economist, Head Pharmacoeconmic unit and Inpatient & IV Oncology Pharmaceutical Services-MODHS, KSA
Prof. Ibrahim Alabbadi, Professor of Pharmacoeconomics and Pharmaceutical Marketing - The University of Jordan, Jordan
Prof. Nadia Al Mazrouei, ISPOR UAE Chapter President and Conference Chair, UAE
Session III: “Balancing Pricing Regulations and Patient Access”
Innovative Pricing & Reimbursement Strategies: Advancing Affordable & PatientCentered Care
Session III: “Balancing Pricing Regulations and Patient Access” Moderated by: Dr. Mouza Alsaadi, Health Economist - Dubai Health Authority, UAE Prof. Suliman Alghnam, Chair of ISPOR Arab Network Executive Director of Surveillance, Saudi Public Health Authority- KSA
By: Prof. Zaheer-Ud-Din Babar, Professor of Clinical Pharmacy and Practice, The University of Huddersfield, UK and Qatar University, Member of WHO Technical Advisory Group (TAG) On Pricing Policies for Medicines Qatar and UK
Balancing Pricing Regulations and Patient Access: Sharing Experience
Session III: “Balancing Pricing Regulations and Patient Access” Moderated by: Dr. Mouza Alsaadi, Health Economist - Dubai Health Authority, UAE Prof. Suliman Alghnam, Chair of ISPOR Arab Network Executive Director of Surveillance, Saudi Public Health Authority- KSA
By: Dr. Asmaa Saad, Head of Pricing Policy Administration and Pharmacoeconomics Unit in Egyptian Drug Authority, Egypt
Key Pillars for a Strategic Framework for Managed Entry Agreements Implementation
Session III: “Balancing Pricing Regulations and Patient Access” Moderated by: Dr. Mouza Alsaadi, Health Economist - Dubai Health Authority, UAE Prof. Suliman Alghnam, Chair of ISPOR Arab Network Executive Director of Surveillance, Saudi Public Health Authority- KSA
By: Prof. Hussain Al Omar, Professor of Pharmacoeconomics and Pharmaceutical Policy and Consultant, Department of Clinical Pharmacy, College of
Pharmacy, King Saud University- Senior Advisor and Expert in Health Technology Assessment, Health Economics, and Health Policy, KSA
Industry Symposium: Unveiling the hidden burden of Chronic spontaneous Urticaria
By: Dr. Mohamed Madbouly, Consultant Dermatologist and head of department at NMC Royal Abu Dhabi, UAE
Opening Speech
ISPOR UAE Conference 2025 official Opening
Prof. Nadia Al Mazrouei, ISPOR UAE Chapter President and Conference Chair, Expert Advisory Board Panel at WHO, Associate Professor at Sharjah University, EMR Pharma Forum President at FIP International, President of Pharmacists Association, UAE
ISPOR UAE Conference 2025 official Opening
Dr Mohamed Tannira, ISPOR UAE Chapter President Elect
ISPOR UAE Conference 2025 official Opening
Prof. Mohamed Farghaly ISPOR UAE Chapter Board Director and Head of Scientific committee, Professor Dubai Medical College, Consultant Family Medicine
ISPOR UAE Conference 2025 official Opening
Prof. Samar Mansour, Professor at GUC and GIU- ISPOR UAE Chapter Board of Director and Co- Chair of Scientific committee Healthcare Transformation Consultant, Egypt
ISPOR UAE Conference 2025 official Opening
Dr. Rob Abbott, CEO and Executive Director of ISPOR International
ISPOR UAE Conference 2025 official Opening
Dr. Robert Selby, Senior Director, Global Engagement ISPOR International
Session IV: “MENA Health Policy: Innovation Through Collaboration”
Opening Presentation for the Panel: HTA implementation, key success ingredients and challenges in MENA countries
Session IV: “MENA Health Policy: Innovation Through Collaboration” Moderated by Prof. Samar Mansour, Professor at GUC and Dean at German International University- ISPOR UAE Chapter Board Director and Co-Chair of Scientific committee- Healthcare Transformation Consultant
By: Dr. Mouna Jameleddine, Director of HTA department at the Tunisian Authority for Assessment and Accreditation in Healthcare (INEAS), Vice chair of INAHTA (the International Network of Agencies for HTA), WHO Expert,Tunisia
Collaborative Health Policy in MENA: Regional Partnerships for Innovation and System Efficiency “HEOR Shared Experience for Best Practice”
Session IV: “MENA Health Policy: Innovation Through Collaboration” Moderated by Prof. Samar Mansour, Professor at GUC and Dean at German International University- ISPOR UAE Chapter Board Director and Co-Chair of Scientific committee- Healthcare Transformation Consultant
Chairperson:
Prof. Samar Mansour, Professor at GUC and Dean at German International University- ISPOR UAE Chapter Board Director and Co-Chair of Scientific committee Healthcare Transformation Consultant, Egypt
Panelists:
Dr. Ahmed Seyam, Deputy CEO for Technical Affairs - Universal Health Insurance Authority- Egypt
Prof. Amal Sedrak, Director of the Central Administration of HTA – UPA- Egypt
Dr. Anas Hamad, Director of Pharmacy, NCCCR; Head of Medication Safety/Quality and Head of Pharmacy Research, HMC; Clinical Associate Professor, QU; Lead of HTA Project, MOPH, Qatar
Prof. Hussain Al Omar, Professor of Pharmacoeconomics and Pharmaceutical Policy and Consultant, Department of Clinical Pharmacy, College of Pharmacy, King Saud University- Senior Advisor and Expert in Health Technology Assessment, Health Economics, and Health Policy, KSA
Dr. Khadeija Al-Marshoudi, ISPOR UAE Chapter Board Director, Head of Planning and Development Section at Emirates Health Service, UAE
Dr. Meriem Hedibel, Research Assistant Professor at Algiers University, Algeria
Dr. Mouna Jameleddine, Director of HTA department at the Tunisian Authority for Assessment and Accreditation in Healthcare (INEAS), Vice chair of INAHTA (the International Network of Agencies for HTA), WHO Expert, Tunisia
Session V: “AI Meets Digital Health: Reshaping HEOR for a Smarter Future”
“Pharmacy in a changing environment Artificial Intelligence and Digital Health”
Session V: “AI Meets Digital Health: Reshaping HEOR for a Smarter Future” Moderated by: Dr. Bandar Al Harbi- Director of Pharmaceutical Services at Prince Sultan Military Medical City-KSA By: Dr. Lars- Ake- Söderlund Vice President International Pharmaceutical Federation (FIP), Sweden
“AI-Driven Frameworks and Real-World Data: Transforming HEOR, HTA, and Policy Decisions”
Session V: “AI Meets Digital Health: Reshaping HEOR for a Smarter Future” Moderated by: Dr. Bandar Al Harbi- Director of Pharmaceutical Services at Prince Sultan Military Medical City-KSA By: Dr. Abeer Al-Rabayah, Head of Center for Drug Policy and Technology Assessment, Pharmacy Department. King Hussein Cancer Center (KHCC), Jordan
Frontiers in HEOR: Transforming Outcomes and HTA – AI-Driven Assessment Frameworks and Regional Case Studies for Policy and Industry Leaders
Chair Person:
Dr. Abeer Al-Rabayah, Head of Center for Drug Policy and Technology Assessment, Pharmacy Department. King Hussein Cancer Center (KHCC), Jordan
Panelists :
Dr.AboBakr Abasaeed, ISPOR UAE Chapter Board Director-Regulatory Affairs Manager at ADCAN Pharma UAE
Dr. Bandar Al Harbi, Director of Pharmaceutical Services at Prince Sultan Military Medical City- KSA
Dr. Heba Mohamed, Pharmacy Program Chair, Higher Colleges of Technology, UAE
Dr. Nicole Gebran, Senior Specialist, Clinical Pharmacy Lead, Dubai Health- UAE
Session VI: “Unlocking Insights with Real-World Evidence (RWE)”
"Advancing HEOR, HTA, and Real-World Data: Driving Smarter Decisions and Equitable Healthcare"
Session VI: “Unlocking Insights with Real-World Evidence (RWE)” Moderated by: Prof. Amal Sedrak, Director of the Central Administration of HTA – UPA- Egypt Dr. Meriem Hedibel, Research Assistant Professor at Algiers University, Algeria By: Dr. Anas Hamad Director of Pharmacy, NCCCR; Head of Medication Safety/Quality and Head of Pharmacy Research, HMC; Clinical Associate Professor, QU; Lead of HTA Project, MOPH, Qatar
Harnessing HEOR & Real-World Data for Public Health and Market Access: MultiCriteria Decision Analysis
Session VI: “Unlocking Insights with Real-World Evidence (RWE)” Moderated by: Prof. Amal Sedrak, Director of the Central Administration of HTA – UPA- Egypt Dr. Meriem Hedibel, Research Assistant Professor at Algiers University, Algeria By: Dr. Alexander Kostyuk, Advisor to Minister of Health, Republic of Kazakhstan
Informing vs. Misleading: The Importance of Methodological Quality in Economic Evaluations
Session VI: “Unlocking Insights with Real-World Evidence (RWE)” Moderated by: Prof. Amal Sedrak, Director of the Central Administration of HTA – UPA- Egypt Dr. Meriem Hedibel, Research Assistant Professor at Algiers University, Algeria By: Dr. Wadih Mina, Health Economics and Market Access Lead, Boston Scientific, Middle East and North Africa. President-Elect of ISPOR Lebanon Chapter, Lebanon
Meet our Speakers:
The ISPOR 2025 United Arab Emirates Chapter Conference brings together a distinguished line-up of speakers, each offering exceptional expertise to inspire impactful discussions and drive innovation in the field of Health Economics & Outcomes Research (HEOR)
Dr. Abeer Al-Rabayah
Speaker
Head of Pharmacy at King Hussein Cancer Center (KHCC), Jordan
Dr. Anas Hamad
Speaker
Director of Pharmacy & Head of Medication Safety/Quality at Hamad Medical Corporation, Clinical Associate Professor at Qatar University
Dr. Alexandr Kostyuk
Speaker
Advisor to the Minister of Health Republic of Kazakhstan
Dr. Asmaa Saad
Speaker
Head of Pharmacoeconomics Unit, Egyptian Drug Authority
Prof. Daoud Al-badriyeh
Speaker
Professor of Pharmacoeconomics and Outcomes Research at Qatar University
Dr. Mouna Jameleddine
Speaker
Director of the HTA and economic evaluation Department-INEAS- WHO Expert, Tunisia Vice-Chair of INAHTA (the International Network of Agencies for HTA)
Prof. Hussain Al-Omar
Speaker
Consultant & Associate Professor, Clinical Pharmacy Department, Director, Health Technology Assessment Unit, King Saud University
Prof. Ibrahim Al-abbadi
Speaker
Professor of Pharmacoeconomics and Pharmaceutical Marketing - The University of Jordan
Dr. Tomasz Kluszczynski
Speaker
Professor at Warsaw University of Technology and Goethe Frankfurt University
Dr. Wadih Mina
Speaker
President-Elect of the ISPOR Lebanon Chapter, Health Economics and Market Access Lead at Boston Scientific
Prof. Zaheer-Ud-Din Babar
Speaker
Professor of Clinical Pharmacy and Practice - Qatar University, Consultant on Pharmaceutical Pricing
Agenda:
Shaping the Future of Health Economics & Outcomes Research: A Visionary Agenda at the ISPOR UAE Chapter 2025 Conference
[pdf id=7213]
[pdf id=7143]
[pdf id=7145]
[pdf id=7138]
[pdf id=7153]
Scientific Committee:
Meet the esteemed Scientific committee behind the conference!
ABSTRACT SUBMISSION
The ISPOR 2025 United Arab Emirates Chapter conference is a platform for transformative discussions in Health Economics & Outcomes Research (HEOR). Seize this opportunity to showcase your ground-breaking research and contribute to the global HEOR community!
Why to Submit an Abstract?
- Connect with thousands of researchers, regulators, payers, and thought leaders
- Contribute your innovative ideas, and novel knowledge to advance the science of HEOR.
- Gain global recognition and widespread dissemination of your work.
Submit an Abstract:
Submission period: 1st of March 2025 – 20th of May 2025.
